Subsequent Events	12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	NOTE 10 – Subsequent Events In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2022 through the date these financial statements were issued and has determined that it has the following material subsequent events to disclose in these financial statements. On October 17, 2022, High Sierra Technologies, Inc. executed an Agreement with Boustead Securities for a Proposed Pre-IPO Financing, Initial Public Offering and Corporate Transactions. This agreement and certain terms and conditions are still being worked out in 2023. On February 10, 2023, an individual loaned High Sierra Technologies, Inc. the sum of $10,000 pursuant to a Promissory Note dated February 10, 2023 which bears interest at a rate of 12% per annum and which is due on August 10, 2023. On March 6, 2023, the Company received $25,000 from Organipure, Inc. as an advance payment of the licensing fees that the Company will be receiving from Organipure, Inc. for the use of the Company’s patented and patent pending technologies.

Subsequent Events

12 Months Ended

Dec. 31, 2022

NOTE 10 – Subsequent Events

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2022 through the date these financial statements were issued and has determined that it has the following material subsequent events to disclose in these financial statements.

On October 17, 2022, High Sierra Technologies, Inc. executed an Agreement with Boustead Securities for a Proposed Pre-IPO Financing, Initial Public Offering and Corporate Transactions. This agreement and certain terms and conditions are still being worked out in 2023.

On February 10, 2023, an individual loaned High Sierra Technologies, Inc. the sum of $10,000 pursuant to a Promissory Note dated February 10, 2023 which bears interest at a rate of 12% per annum and which is due on August 10, 2023.

On March 6, 2023, the Company received $25,000 from Organipure, Inc. as an advance payment of the licensing fees that the Company will be receiving from Organipure, Inc. for the use of the Company’s patented and patent pending technologies.

High Sierra Technologies, Inc. 10-K